The confusion of medical price cut rules

After numerous pharmaceutical companies in Hunan and Zhejiang have abandoned their bids in large areas, the cold wind in the medical field continues to squeak, and it is no longer a novelty to look at the lowest prices in the country. The Chongqing Pharmaceutical Exchange recently added another weapon to reduce the price of drugs in the waist and waist. It collected and linked the linked prices of Anhui county-level hospitals that were previously discussed in the industry and had no precedent but only a low price, breaking the provincial standard and referring only to other regions. The bidding rules of the subject have added an unprecedented precedent.

The confusion of medical price cut rules

For a time, enterprises are constantly puzzled and doubts are constantly being drawn up so as to be wild and self-willed to formulate various linked rules. The lowest price in the province is not yet counted, but it is also necessary to go back to a certain city, certain county hospitals, or a certain family. How can hospitals and pharmacies, and pharmaceutical companies, conduct future marketing? Occasional quote mistakes and malicious bids allow companies to correct and survive?

The relevant procedures and design of the national drug price negotiation are in full swing and are being prepared. The main purpose is to continue to compress medicines and supplement hospitals with 15% of profit, and continue to “make up for medicine”. The provincial standard decline has reached more than 10% or even higher. How many products have such a high profit for cutting meat? If you fail to reach a business, you must lay off your staff. Even if the companies can't help but accept low-cost entry, they also lack the guarantee of sales. Eventually, it is still a dead end. How can the input and output of the pharmaceutical industry and corporate interests be protected? In this way, the serious reversal of the industry and business rules, and the adoption of a one-size-fits-all arbitrary policy can only leave products with genuinely high drug prices. Instead, many brand drugs and new drugs with more assured quality and efficacy are expelled from the hospital. The suspension of business, the demise of products, and the loss of employees' protection.

In recent years, people’s clothing, food, housing, and housing prices have risen by at least 10% to 20% each year, except that the pharmaceutical industry does not move. The financing cost of corporate financing is already 7% to 10% or even higher. The pressure on hardware investment is huge. The raw material price increase is unstoppable. The R&D and marketing cycles are out of reach. When the drug price issue is widely criticized, whether or not many pharmaceutical companies have considered how to survive? ? The vigorous housing reform is based on the country’s heavy investment to support real estate revival. The medical reform will be simply positioned as a drug reform, deviating from the realities and laws of the industry and the company's operations, and whether it will be changed more and more. Can the medical reform specialists and bargaining experts be responsible for outsourcing the reduced-price corporate products and help the company pay employees?

Imagine a market economy with a planned economy, substitute theoretical experience with the experience of developed countries in place of the actual operating laws of other industries, and develop governance schemes for developing countries, replace industrial communication and dialogue with administrative intervention, and simply shift the problems of one industry to another. The more deviated from the essence.

The actual internal cause of expensive medical treatment

The enterprises complained about the constant cries, the opinions of the public were numerous, and how were medical expenses and drug prices high? How can we specialize in governance instead of drastically taking wages, killing chickens and eggs, and treating patients with headaches and foot pains, splitting and theoretically carrying out drug reforms?

1. The cost of medical insurance is equal to the consumption of public funds, which promotes major medical services, major tests, and large prescriptions

The country has continuously increased its medical investment and realized the original intention of medical insurance and mutual aid. However, due to the lack of management and supervision of medical institutions, medical insurance costs are like state-owned enterprises' public funds. They don't feel bad about it. The more hospitals and individuals they use, the more profit they have become. The state subsidy portion is not yet one outpatient fee in the first-tier cities. The kites for medical expenses have already been flying high, and the theoretical assumption that reducing the proportion of medicines to suppress the increase will eventually make the kites dislocate and drift to the sky. Only by facing the high cost of medical treatment, can the kites be fully controlled and reduced to reduce the overall cost of medical care. Pull back to the horizon.

After numerous pharmaceutical companies in Hunan and Zhejiang have abandoned their bids in large areas, the cold wind in the medical field continues to squeak, and it is no longer a novelty to look at the lowest prices in the country. The Chongqing Pharmaceutical Exchange recently added another weapon to reduce the price of drugs in the waist and waist. It collected and linked the linked prices of Anhui county-level hospitals that were previously discussed in the industry and had no precedent but only a low price, breaking the provincial standard and referring only to other regions. The bidding rules of the subject have added an unprecedented precedent.

2, lack of standardized medical and prescription audits, lack of patient selection

A small skin disease can give one or twenty kinds of similar drugs; a small hospital doctor is much taller than the prescribing doctor; a high price and large prescription no matter what the patient's constitution, what is simple, and the name of the patient is correct. ... Patients as vulnerable groups have only the right to purchase, and lack the right to know and choose. Only comprehensively popularize common people’s health knowledge and medical knowledge, promote healthy lifestyles, improve the standardization of medical institutions, strengthen supervision, hand over the right of choice to patients, and provide public health consultants to answer doubts and dispel doubtful rights, so as to effectively improve them.

3, a medical marketing pen, drug companies can only look complexion

Doctors are not prescribing, and even the best medicine can only press the warehouse. Companies cannot determine the destiny of a product. Whether a hospital's admission threshold can be overcome or not, and whether doctors choose to use your medicine as one of the most important fate judgements for a product. When everything is left to the doctor to determine the patient's medical costs, decide what medicine to use, rather than standardize the service first, patient satisfaction is supreme, you must know.

4, hanging network procurement does not drop dead, drop also died

The embarrassing situation of linking nets represented by low-priced drugs has become almost the fate of domestic companies. Now it is far beyond the scope of homogenized product bidding and price-fixing. Almost every glamorous enterprise and bright and light product are beginning to suffer without exception. . Regardless of whether the purchase of the nets, the second bargaining or the pharmacy trusteeship, without exception, greatly increases the operating costs of the company, the company does not drop or die, and the same is dead. The only thing that can survive is the full price of water. In fact, the high drug prices are also being pushed by the waves of the Yangtze River.

5, the additional cost is much higher than the factory cost

Just as bread cannot be priced in the price of flour, the high R&D costs, hardware investment, huge marketing costs, raw material costs, labor costs, financial costs, taxes, and logistics costs of pharmaceutical companies are rising year after year. These additional costs are far Higher than the production cost. The corporate R&D and marketing cycle is long, the process is rugged, products are put into the market and the costs are not recoverable. The company's marketing is not supported by the government. Instead, it is heavily resistant. New drugs are not yet on the market and they become old medicines. Losing money, companies are no longer willing to invest in new drug research and development and market cultivation, with gold will grow more comfortable.

6. There is no way to determine drug prices in circulation

Drugs are special commodities that cannot be sold directly to consumers. The agency system is an effective way to reduce corporate expenses and improve the marketing efficiency and results of the company. At the same time, it effectively drives the reduction of drug prices and returns to the people. It is more market competitive and price competitive than large companies. The cost of self-supporting methods far exceeds the cost of agency. The drug sales price is determined by the price of the linked network. It is difficult to determine the price of drugs in circulation, there is no marketing network and marketing channels, no marketing requirements, and although the products of enterprises are good, the medical institutions are in dire need of one but they cannot sell one.

When the reform of public hospitals was based on the premise and prelude of wild drug prices, everything remained in the stage of planned economy, administrative command, theoretical operation, confusion of position, and material deviation, and medical expenses could only continue to flutter and drug prices dropped. It is no longer important. Since the reform of medical reform has just proposed the basic core points of improving the standardization of medical institutions and service satisfaction, one cannot help worrying. Will drug prices become more and more subdued, and it will become increasingly expensive to see a doctor? Or maybe both dance together, what do you think?